News | October 30, 2024
GlaxoSmithKline Pharmaceuticals Q2 FY25 revenue crosses Rs. 1,000 Cr
The Pediatric vaccine portfolio delivered double-digit growth and maintained its market leadership in the private market
The Pediatric vaccine portfolio delivered double-digit growth and maintained its market leadership in the private market
The company can now expand its business horizon into the area of pharmaceutical applications in the USA
Emcure will play a crucial role in ensuring the availability of high-quality, low-cost versions of lenacapavir in 120 countries
Stable profits, low leverage to keep credit profiles comfortable
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
Effective, holistic, science-backed targeted solutions for symptomatic treatment
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
India Business grew by 11.9% YoY to Rs. 1196.2 crore
The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity
EBITDA at Rs. 250 crore, up 47% YoY, with 35% EBITDA margin
Subscribe To Our Newsletter & Stay Updated
